Facet browsing currently unavailable
Page 1 of 87 results
Sort by: relevance publication year
Altered expression in liver cancer with various hepatic blood flow occlusions: A pilot RNA sequencing study JOURNAL ARTICLE published June 2023 in iLIVER Research funded by Natural Science Foundation of Beijing Municipality (7202235) |
Radiomics/Radiogenomics in hepatocellular carcinoma: Applications and challenges in interventional management JOURNAL ARTICLE published June 2022 in iLIVER |
Analysis of efficacy and safety for the combination of regorafenib and PD-1 inhibitor in advanced hepatocellular carcinoma: A real-world clinical study JOURNAL ARTICLE published March 2024 in iLIVER |
Publication characteristics and visualized analysis of research about liver sinusoidal endothelial cells JOURNAL ARTICLE published March 2024 in iLIVER |
The potential role of extracellular vesicles as hepatic diagnostic and therapeutic tools: Can the dream come true? JOURNAL ARTICLE published March 2024 in iLIVER |
Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: Review and bibliometric JOURNAL ARTICLE published March 2024 in iLIVER |
Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma JOURNAL ARTICLE published March 2024 in iLIVER |
Associating liver partition and portal vein ligation for staged hepatectomy for colorectal liver metastasis: a single-center experience JOURNAL ARTICLE published March 2022 in iLIVER Research funded by National Natural Science Foundation of China (82150004) |
Chronic hepatitis C in hemodialysis patients: Prevalence and liver fibrosis impact in the National Center for Renal Health in Peru JOURNAL ARTICLE published September 2022 in iLIVER |
Viral diseases in Africa: Preventing the outbreak of acute hepatitis of unknown etiology JOURNAL ARTICLE published December 2022 in iLIVER |
Myeloid-derived suppressor cells in cancer JOURNAL ARTICLE published June 2022 in iLIVER |
Prednisolone therapy accelerates recovery of severe drug-induced liver injury: A prospective, randomized controlled study JOURNAL ARTICLE published September 2023 in iLIVER |
Evaluating Tislelizumab, Lenvatinib, and FOLFOX4-HAIC as a Conversion Therapy for Unresectable Hepatocellular Carcinoma JOURNAL ARTICLE published September 2023 in iLIVER |
MAFLD was more easily diagnosed than NAFLD in liver transplant recipients with abnormal liver function JOURNAL ARTICLE published September 2022 in iLIVER |
Transarterial chemoembolization in combination with programmed death-1/programmed cell death-ligand 1 immunotherapy for hepatocellular carcinoma: A mini review JOURNAL ARTICLE published December 2022 in iLIVER Research funded by National Key Research and Development Program of China (2017YFC0909900) |
General-motors diet: A quick fix for steatotic live liver donors JOURNAL ARTICLE published September 2023 in iLIVER |
The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease JOURNAL ARTICLE published March 2022 in iLIVER |
The analysis of the adherence of liver transplant recipients to immunosuppressant treatment, their self-control, and self-management in the post-transplantation period JOURNAL ARTICLE published June 2023 in iLIVER |
Feasibility of surgical application of the ligamentum teres hepatis: a review JOURNAL ARTICLE published March 2023 in iLIVER |
Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment? JOURNAL ARTICLE published March 2022 in iLIVER Research funded by Key Research and Development Program of Zhejiang Province (2019C03050) | National Natural Science Foundation of China (82003248) |